Antonio R Pera
CIK 1689325 · President, Par Pharmaceutical · last filed 2026-06-10
Antonio R Pera is a President, Par Pharmaceutical who has filed 25 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for ANIP, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$1.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.21M
2
25
-$1.69M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ANIP | Director | 27,017 | $81.68 | $2.21M | -$1.69M | 12 | 2026-06-10 |
| Endo International plc (ENDP) Delisted | President, Par Pharmaceutical | 65,648 | $0.29 | $19.2K | $0 | 13 | 2019-04-04 |
Recent Filings
25 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | ANIP | Grant (A) | +4,357 | $0 | EDGAR |
| 2025-09-04 | ANIP | Sell (S) | −7,292 | -$692.3K | EDGAR |
| 2025-08-20 | ANIP | Sell (S) | −5,421 | -$486.4K | EDGAR |
| 2025-05-27 | ANIP | Grant (A) | +4,336 | $0 | EDGAR |
| 2024-05-23 | ANIP | Grant (A) | +4,410 | $0 | EDGAR |
| 2024-03-06 | ANIP | Sell (S) | −7,000 | -$456.4K | EDGAR |
| 2023-08-15 | ANIP | Sell (S) | −3,000 | -$181.1K | EDGAR |
| 2023-05-24 | ANIP | Grant (A) | +6,865 | $0 | EDGAR |
| 2022-04-29 | ANIP | Grant (A) | +10,049 | $0 | EDGAR |
| 2021-12-09 | ANIP | Buy (P) | +3,000 | $126.8K | EDGAR |